Literature DB >> 14581855

The ovarian surface epithelium: simple source of a complex disease.

K C Choi1, N Auersperg.   

Abstract

The ovarian surface epithelium (OSE) is thought to be the origin of most ovarian cancers in humans. OSE is a single cell layer of squamous or cuboidal cells on the surface of ovaries. In contrast to its relatively simple structure, it gives rise to a highly complex group of neoplasms, the epithelial ovarian carcinomas. Thus, in this review, we summarize the development and the main characteristics of normal adult OSE with emphasis on those properties that might contribute to its propensity to undergo neoplastic progression. Secondly, a brief comparison of the biology and endocrinology of normal and neoplastic OSE is being described to understand the mechanisms in the transformation of normal OSE to its neoplastic counterparts. Lastly, recent advances in experimental approaches including in vitro and in vivo models that have contributed to our understanding of the nature of epithelial ovarian cancers are being briefly explored.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581855

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  5 in total

1.  Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.

Authors:  Weiwei Shan; Imelda Mercado-Uribe; Jing Zhang; Daniel Rosen; Shiwu Zhang; Jianjun Wei; Jinsong Liu
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

Review 2.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009

3.  Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.

Authors:  Michael S Anglesio; Jeremy M Arnold; Joshy George; Anna V Tinker; Richard Tothill; Nic Waddell; Lisa Simms; Bianca Locandro; Sian Fereday; Nadia Traficante; Peter Russell; Raghwa Sharma; Michael J Birrer; Anna deFazio; Georgia Chenevix-Trench; David D L Bowtell
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

4.  Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma.

Authors:  G Y Zhang; N Ahmed; C Riley; K Oliva; G Barker; M A Quinn; G E Rice
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

5.  Targeting the EGF receptor for ovarian cancer therapy.

Authors:  Reema Zeineldin; Carolyn Y Muller; M Sharon Stack; Laurie G Hudson
Journal:  J Oncol       Date:  2009-12-28       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.